LOW-VOLUME · HOSP-HEAVY
dipyridamole Side Effects
dipyridamole (also sold as Persantine) is a LOW-VOLUME FAERS extract #413 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 51.4% mention hospitalization (1,894 reports).
Data updated 2026-05-15
- 3,682
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
dipyridamole: 51.4% mention hospitalization (1,894 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #413 of 524 by FAERS report count.
Thinner FAERS extract for dipyridamole (Persantine) (3,682 reports #413 of 524 by FAERS report count). 51.4% mention hospitalization (1,894 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2002–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
FALL leads 545 of 3,682 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (1,235 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (459 reports, 12.5%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 73 |
| PNEUMONIA | 37 |
| CEREBRAL HAEMORRHAGE | 29 |
| CEREBROVASCULAR ACCIDENT | 29 |
| RENAL FAILURE | 27 |
| MULTI-ORGAN FAILURE | 25 |
| SEPSIS | 25 |
| EMBOLISM | 22 |
| DIARRHOEA | 19 |
| NEUROLOGICAL SYMPTOM | 19 |
| HAEMORRHAGE INTRACRANIAL | 18 |
| HYPOTENSION | 18 |
| MYOCARDIAL INFARCTION | 18 |
| NEUTROPENIC SEPSIS | 18 |
| DYSPNOEA | 17 |
| GASTROINTESTINAL HAEMORRHAGE | 17 |
| HAEMORRHAGE | 17 |
| NAUSEA | 17 |
| ANAEMIA | 16 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1,894, 51.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FALL | 525 |
| HYPOTENSION | 484 |
| COGNITIVE DISORDER | 479 |
| PAIN | 462 |
| DEPRESSED LEVEL OF CONSCIOUSNESS | 459 |
| ORTHOSTATIC HYPOTENSION | 456 |
| CONSTIPATION | 455 |
| BALANCE DISORDER | 449 |
| SEDATION COMPLICATION | 446 |
| BLOOD CALCIUM DECREASED | 435 |
| CREATININE RENAL CLEARANCE DECREASED | 435 |
| MOBILITY DECREASED | 430 |
| SEDATION | 425 |
| TOXICITY TO VARIOUS AGENTS | 366 |
| DYSPNOEA | 170 |
| DRUG INTERACTION | 133 |
| VOMITING | 82 |
| CEREBROVASCULAR ACCIDENT | 77 |
How to read dipyridamole FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 3,682 voluntary reports linked to dipyridamole (Persantine), 2002-2025. Death is listed on 459 (12.5%). Hospitalization appears on 1,894 (51.4%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with dipyridamole
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 3,669 FAERS cases (Δ 13 lighter vs dipyridamole); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,736 FAERS cases (Δ 54 heavier vs dipyridamole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,599 FAERS cases (Δ 83 lighter vs dipyridamole); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,554 FAERS cases (Δ 128 lighter vs dipyridamole); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 49.6 pp vs dipyridamole's DEATH-HEAVY): CASELOAD · HOSP-MID.
dipyridamole stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.